REGULUS THERAPEUTICS INC's ticker is RGLSXXXX and the CUSIP is 75915K101. A total of 85 filers reported holding REGULUS THERAPEUTICS INC in Q2 2016. The put-call ratio across all filers is 0.13 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $28,000 | -24.3% | 27,319 | -8.1% | 0.00% | – |
| Q3 2017 | $37,000 | -73.4% | 29,728 | -52.0% | 0.00% | – |
| Q4 2016 | $139,000 | -25.7% | 61,881 | +8.8% | 0.00% | – |
| Q3 2016 | $187,000 | -60.7% | 56,874 | -17.2% | 0.00% | -100.0% |
| Q1 2016 | $476,000 | -49.1% | 68,682 | -36.0% | 0.00% | 0.0% |
| Q4 2015 | $935,000 | +175.8% | 107,267 | +106.9% | 0.00% | – |
| Q3 2015 | $339,000 | +59.9% | 51,834 | +314.4% | 0.00% | – |
| Q1 2015 | $212,000 | -11.7% | 12,508 | -50.8% | 0.00% | – |
| Q3 2013 | $240,000 | – | 25,411 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 4,039,823 | $26,420,000 | 3.79% |
| Foresite Capital Management II, LLC | 1,750,269 | $11,447,000 | 3.48% |
| ARGONAUT CAPITAL MANAGEMENT CORP | 75,000 | $491,000 | 1.65% |
| Abingworth LLP | 327,350 | $2,138,000 | 1.25% |
| Trellus Management Company, LLC | 100,000 | $654,000 | 0.96% |
| Cormorant Asset Management, LP | 896,522 | $5,863,000 | 0.94% |
| DAFNA Capital Management LLC | 90,000 | $589,000 | 0.58% |
| ORACLE INVESTMENT MANAGEMENT INC | 749,064 | $4,898,000 | 0.50% |
| Foresite Capital Management II, LLC | 250,000 | $1,635,000 | 0.50% |
| Foresite Capital Management II, LLC | 250,000 | $1,635,000 | 0.50% |